share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144:拟议出售证券
美股SEC公告 ·  08/06 16:54
Moomoo AI 已提取核心信息
Recursion Pharmaceuticals, Inc. Director Borgeson Blake is set to sell 11,447 Class A shares of the company on 08/06/2024, as per the latest filing. These shares, valued at approximately $78,083.44, were originally acquired on 09/01/2016 as founders shares and as part of compensation from the issuer. This planned sale follows a series of transactions over the past three months, where a total of 77,289 shares were sold for gross proceeds of $694,221.07.
Recursion Pharmaceuticals, Inc. Director Borgeson Blake is set to sell 11,447 Class A shares of the company on 08/06/2024, as per the latest filing. These shares, valued at approximately $78,083.44, were originally acquired on 09/01/2016 as founders shares and as part of compensation from the issuer. This planned sale follows a series of transactions over the past three months, where a total of 77,289 shares were sold for gross proceeds of $694,221.07.
根据最新报告,Recursion Pharmaceuticals, Inc. 的董事Borgeson Blake将于2024年08月06日出售11,447股A类公司股票。这些股票价值约为78,083.44美元,最初于2016年09月01日作为创始人股份和向发行人获得的补偿股份获得。此次计划的出售是在过去三个月中进行的一系列交易之后进行的,这些交易总共卖出了77,289股股票,总交易额达到694,221.07美元。
根据最新报告,Recursion Pharmaceuticals, Inc. 的董事Borgeson Blake将于2024年08月06日出售11,447股A类公司股票。这些股票价值约为78,083.44美元,最初于2016年09月01日作为创始人股份和向发行人获得的补偿股份获得。此次计划的出售是在过去三个月中进行的一系列交易之后进行的,这些交易总共卖出了77,289股股票,总交易额达到694,221.07美元。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息